Turmeric Extract (95% Curcuminoids)

Turmeric Extract (95% Curcuminoids) is a standardised botanical ingredient derived from the rhizomes of Curcuma longa, concentrated to deliver a minimum 95% curcuminoid content. The primary curcuminoids — curcumin, demethoxycurcumin, and bisdemethoxycurcumin — are the bioactive compounds that have made turmeric one of the most researched botanicals in the nutraceutical industry.

Brands use turmeric extract in gummies because it offers a familiar, consumer-trusted ingredient with broad positioning potential across joint comfort, healthy ageing, sports recovery, and daily wellness. Its warm, earthy flavour is easily masked with fruit profiles, making it well-suited for gummy formats. However, the ingredient is on the EU on-hold list for botanical health claims, meaning brands must rely on co-formulated nutrients for claim coverage and position around general wellness rather than specific health outcomes.

Origin and history

Turmeric has been used for thousands of years in Ayurvedic and traditional Chinese medicine, primarily as a culinary spice and wellness ingredient. The rhizome of Curcuma longa, a member of the ginger family, has been cultivated across South Asia for its distinctive golden-yellow colour and earthy flavour profile.

Industrial production of standardised turmeric extract involves drying and grinding the rhizomes, followed by solvent extraction to concentrate the curcuminoid fraction to 95% purity. This standardisation ensures batch-to-batch consistency in active compound content, which is critical for commercial nutraceutical applications. The extract is then formulated into various delivery formats, including gummies, where it can be combined with bioavailability-enhancing ingredients like black pepper extract (piperine).

Scientific overview

Curcuminoids are polyphenolic compounds that interact with multiple molecular targets in the body, including enzymes, transcription factors, and signalling pathways. The primary challenge with curcumin is its poor oral bioavailability — less than 5% of ingested curcumin reaches systemic circulation due to rapid metabolism and poor absorption in the gastrointestinal tract. This is why co-formulation with piperine, which inhibits glucuronidation and enhances absorption, is considered essential for effective supplementation.

Bioavailability enhancement strategies include co-formulation with piperine (typically 5-10 mg per serving), use of water-dispersible forms, liposomal encapsulation, and nanoparticle technologies. The 95% curcuminoid standardisation ensures consistent dosing of the active compounds, though the specific ratio of curcumin to demethoxycurcumin and bisdemethoxycurcumin can vary between suppliers.

From a manufacturing perspective, turmeric extract is heat-stable and soluble in gummy formulations, making it a practical choice for gummy production. The earthy flavour profile requires masking with fruit flavours such as orange, mango, or berry. Cost-per-mg is moderate compared to other botanical extracts, though the need for piperine co-formulation adds to the overall ingredient cost. Stability testing is recommended to confirm colour and potency retention over the product's shelf life.

Turmeric is one of the most familiar and commercially understood gummy actives across EU and US markets. Consumer awareness of turmeric is exceptionally high, driven by years of mainstream media coverage and retail presence. This familiarity reduces the need for extensive consumer education, making it an attractive entry point for brands launching a gummy range. Common positioning angles include joint comfort, healthy ageing support, sports recovery, and daily wellness.

From a formulation and manufacturing perspective, turmeric extract performs well in gummy formats. It is heat-stable, soluble, and can be dosed at effective levels (500-2000 mg per serving) without compromising gummy texture or stability. The earthy flavour is easily masked with fruit profiles, and the golden-yellow colour can be leveraged as a visual cue for the ingredient's natural origin. The primary formulation consideration is the mandatory co-formulation with piperine to address bioavailability — brands should ensure this is clearly communicated on pack and in marketing materials.

For pack copy, brands must exercise strict claim discipline. As turmeric is on the EU on-hold list for botanical health claims, no specific health claims are permitted in EU consumer-facing copy. Positioning should focus on general wellness, joint comfort, and healthy ageing without making disease-related or structure-function claims. DAT reviews claim wording per project to ensure compliance with target-market regulations. For US markets, structure-function claims are permitted under DSHEA with the appropriate FDA disclaimer.